Unit D, Llantrisant Business Park,
Tel: 01443 229334
LinkedIn: @Purolite Healthcare & Life Sciences
- 2022 International Trade
Since 1981, Purolite has grown into the world’s premier resinbased separation, purification and extraction technology manufacturer and innovation leader, with manufacturing facilities, advanced research laboratories and over 1100 people employed worldwide.
It provides APIs, enzyme carriers, immobilised enzymes and chromatographic resins of the highest quality, to support research and development and production-scale applications in global pharmaceutical, food and beverage, bioprocessing, cosmetics and fine chemical markets.
Its resins are vital raw materials in the global production of monoclonal antibody treatments for ailments such as cancer, rheumatoid arthritis and diabetes, and they have also been incorporated into the manufacturing process for treatments and vaccines for Covid-19.
The company has over 6,000 businesses as customers in over 50 countries worldwide. Its Praesto® line of resins for the previously mentioned therapies are solely developed and manufactured in Wales, and Purolite was family owned and operated until 2021, when it was acquired for $3,7billion by Ecolab.